-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Phibro Animal Health, Lowers Price Target to $44

Benzinga·05/14/2026 19:02:49
Listen to the news
Citigroup analyst Daniel Grosslight maintains Phibro Animal Health (NASDAQ:PAHC) with a Neutral and lowers the price target from $62 to $44.